BioWorld

Feb. 21, 2008

View Archived Issues

Pfizer $195M Deal for Encysive Called a 'Good Deal' For Both

Read More

First Working Pancreatic Beta Cells Derived from ESCs

Read More

Bioheart Squeezes Out IPO Window with Meager $5.8M

Read More

Antisense Licenses MS Drug to Teva for $2M Up Front

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Acceleron, Celgene in Potential $1.8B Bone Loss Collaboration

When it came to signing its first biotech collaboration since being founded in 2003, Acceleron Pharma Inc. made sure it was a big one. (BioWorld Today) Read More